文献速递运动医学关节外科

膝关节骨软骨同种异体移植:5年失败情况分析

Osteochondral Allograft Transplantation of the Knee: Analysis of Failures at 5 Years.
PubMed 文献 · Am J Sports Med · 2017-01-05

研究纳入224例连续接受骨软骨同种异体移植(OAT)的患者,最终180例(随访率80%)完成平均5.0年随访。平均5年再手术率为37%,同种异体移植物存活率为87%;既往同侧膝关节手术次数可预测再手术和失败,体重指数可预测失败。

要点

  • 平均5年随访时再手术率为37%,同种异体移植物存活率为87%。
  • 既往同侧膝关节手术次数是再手术和失败的独立预测因素。
  • 关节镜清理时移植物完整者中82%疗效显著改善,18%最终进展为失败。

核心结论

  • 本系列中,OAT术后平均5年再手术率为37%,同种异体移植物存活率为87%。
  • 既往同侧膝关节手术次数可预测再手术和失败,体重指数可预测失败。
  • 关节镜清理时移植物完整的患者中82%获得显著改善,18%最终进展为失败。

研究设计与样本

  • 病例系列研究,证据等级4级。
  • 回顾性分析前瞻性收集的224例连续患者数据,均由单一术者行OAT,至少随访2年。
  • 最终180例患者符合纳入标准(随访率80%),平均年龄32.7±10.4岁,52%为男性,平均随访5.0±2.7年。

主要发现

  • 180例中172例(96%)在OAT术前同侧膝关节平均接受过2.5±1.7次手术。
  • 48%的OAT为孤立手术,52%同时行合并手术,其中65例(36%)行半月板同种异体移植(MAT)。
  • 66例(37%)在平均2.5±2.5年时接受再手术,其中32%(21/66)接受额外再手术(范围1-3次)。
  • 首次再手术中91%行关节镜清理,83%显示移植物完整;其中9例最终在平均4.1±1.9年时进展为失败。
  • 24例(13%)在指数OAT术后平均3.6±2.6年时判定为失败,原因包括翻修OAT(n=7)、转为关节置换(n=12)或关节镜手术见移植物整合不良(n=5)。

临床怎么用

  • 作者认为,上述信息可用于向患者说明OAT后再手术的意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Osteochondral allograft transplantation (OAT) is being performed with increasing frequency, and the need for reoperations is not uncommon. PURPOSE: To quantify survival for OAT and report findings at reoperations. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: A review of prospectively collected data of 224 consecutive patients who underwent OAT by a single surgeon with a minimum follow-up of 2 years was conducted. The reoperation rate, timing of reoperation, procedure performed, and findings at surgery were reviewed. Failure was defined by revision OAT, conversion to knee arthroplasty, or gross appearance of graft failure at second-look arthroscopic surgery. RESULTS: A total of 180 patients (mean [±SD] age, 32.7 ± 10.4 years; 52% male) who underwent OAT with a mean follow-up of 5.0 ± 2.7 years met the inclusion criteria (80% follow-up). Of these, 172 patients (96%) underwent a mean of 2.5 ± 1.7 prior surgical procedures on the ipsilateral knee before OAT. Forty-eight percent of OAT procedures were isolated, while 52% were performed with concomitant procedures including meniscus allograft transplantation (MAT) in 65 (36%). Sixty-six patients (37%) underwent a reoperation at a mean of 2.5 ± 2.5 years, with 32% (21/66) undergoing additional reoperations (range, 1-3). Arthroscopic debridement was performed in 91% of patients with initial reoperations, with 83% showing evidence of an intact graft; of these, 9 ultimately progressed to failure at a mean of 4.1 ± 1.9 years. A total of 24 patients (13%) were considered failures at a mean of 3.6 ± 2.6 years after the index OAT procedure because of revision OAT (n = 7), conversion to arthroplasty (n= 12), or appearance of a poorly incorporated allograft at arthroscopic surgery (n = 5). The number of previous surgical procedures was independently predictive of reoperations and failure; body mass index was independently predictive of failure. Excluding the failed patients, statistically and clinically significant improvements were found in the Lysholm score, International Knee Documentation Committee score, Knee injury and Osteoarthritis Outcome Score, and Short Form-12 physical component summary at final follow-up ( P < .001 for all), with inferior outcomes (albeit overall improved) in patients who underwent a reoperation. CONCLUSION: In this series, there was a 37% reoperation rate and an 87% allograft survival rate at a mean of 5 years after OAT. The number of previous ipsilateral knee surgical procedures was predictive of reoperations and failure. Of the patients who underwent arthroscopic debridement with an intact graft at the time of arthroscopic surgery, 82% experienced significantly improved outcomes, while 18% ultimately progressed to failure. This information can be used to counsel patients on the implications of a reoperation after OAT.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Frank RM, Lee S, Levy D, et al. Osteochondral Allograft Transplantation of the Knee: Analysis of Failures at 5 Years. Am J Sports Med. 2017. PMID: 28056527. doi:10.1177/0363546516676072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。